ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,572Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 81

$709K Total Retail Price of All Prescriptions

Rank: 23 out of 81

325 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 325 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,208 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
DONEPEZIL HCL 431 418 1 8
LISINOPRIL 368 300 2 2
FUROSEMIDE 367 316 3 1
AMLODIPINE BESYLATE 360 321 4 6
NAMENDA 295 295 5 11
LEVOTHYROXINE SODIUM 243 205 6 3
METOPROLOL TARTRATE 231 205 7 7
CITALOPRAM HBR 213 211 8 10
QUETIAPINE FUMARATE 193 175 9 31
OMEPRAZOLE 179 138 10 4
DIVALPROEX SODIUM 178 154 11 25
MIRTAZAPINE 175 175 12 14
GABAPENTIN 172 141 13 13
WARFARIN SODIUM 168 157 14 9
METOPROLOL SUCCINATE 159 158 15 22
METFORMIN HCL 135 114 16 15
TRAMADOL HCL 133 112 17 17
SERTRALINE HCL 129 116 18 19
ATENOLOL 115 105 19 28
HYDROCHLOROTHIAZIDE 112 104 20 21
TRAZODONE HCL 112 107 20 20
SIMVASTATIN 111 95 22 5
RISPERIDONE 108 87 23 26
TAMSULOSIN HCL 105 92 24 29
HYDRALAZINE HCL 97 96 25 52
LANTUS 97 77 25 23
EXELON 95 78 27 47
OLANZAPINE 94 92 28 55
POTASSIUM CHLORIDE 92 67 29 16
LEVETIRACETAM 84 65 30 48
ISOSORBIDE MONONITRATE ER 80 80 31 38
GLIPIZIDE 79 79 32 46
ATORVASTATIN CALCIUM 77 61 33 18
ADVAIR DISKUS 75 72 34 67
ABILIFY 72 42 35 105
ALLOPURINOL 69 69 36 41
ESCITALOPRAM OXALATE 63 60 37 42
SEROQUEL 61 59 38 79
DIGOXIN 61 52 38 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 61 38 99
SPIRIVA 60 48 41 76
FINASTERIDE 57 53 42 93
SPIRONOLACTONE 57 57 42 70
PANTOPRAZOLE SODIUM 56 43 44 72
LIDODERM 54 54 45 43
SANTYL 54 52 45 130
NOVOLIN N 53 36 47 227
CYMBALTA 52 52 48 30
METOCLOPRAMIDE HCL 52 51 48 118
COLCRYS 51 51 50 221
KLOR-CON M20 51 35 50 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.